Michael Halstead Net Worth & Insider Trades

Michael Halstead - EVP and General Counsel, Intra-Cellular Therapies, Inc

As of December 2, 2022

What is Michael Halstead's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's EVP and General Counsel, Michael Halstead, is estimated to be about $20.32M . Michael Halstead owns about 0 unit of Intra-Cellular Therapies, Inc common stock. In the last 8 years at Intra-Cellular Therapies, Inc, Michael Halstead has sold an estimated value of $19.13M worth.

What is Michael Halstead's Past Insider Trading?

Michael Halstead's largest purchase order was 176,863 units , worth over $2.9M on December 23, 2021. Michael Halstead's largest sale order was 176,863 units , worth over $8.41M on December 23, 2021. In total, Michael Halstead has made about 26 transactions over 8 years of their time at Intra-Cellular Therapies, Inc. Michael Halstead usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 50,000 units , worth over $2.69M on December 2, 2022.

Michael Halstead

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael Halstead's Salary in 2020?

As EVP and General Counsel of Intra-Cellular Therapies, Inc, Michael Halstead has a total base salary of $512,000 . Michael Halstead received compensation valued at about $2,449,906 in 2020 after becoming EVP and General Counsel. The vast majority of their compensation came in the form of a bonus of $320,000 , stock awards of $1,119,985 , option awards of $479,990 , and other compensation of $17,931 .

What is Michael Halstead's' Mailing Address?

  • Mailing address is C/o Warner Chilcott Corporation 100 Enterprise Drive Rockaway NJ 07866 NJ

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on December 2, 2022 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $105.92M and bought an estimated value of $63.6M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1